BioAZ raises $1M to accelerate biotech innovation for animal well-being
BioAZ is proud to announce a $1M (€900k) fundraising round with the support of its historical shareholders and leading veterinary business angels.
Investors include Group Cristal, VANE, Animal Health Angels, and “Cercle des Vétérinaires Investisseurs”, key players committed to transforming animal health through innovation.
This funding will boost our R&D efforts, strengthen scientific collaborations, and support the industrial rollout of our first biotech solutions.
At the crossroads of biotechnology, veterinary medicine, and sustainability, BioAZ is building the future of animal well-being.
We’re grateful for the trust of our investors and excited to scale our impact in the animal health ecosystem.
Together, we’re driving meaningful change for animals, vets, and the planet.